This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Adda Biotech Inc., Other. Active years: 2019-2021.
Company Filing History:
2 out of 3 
2 out of 834,350 Years Active: 2019-2021
Title: Han Jie - Innovator in Biopharmaceuticals
Introduction
Han Jie is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of diabetes. With a total of 2 patents, his work focuses on innovative solutions that aim to improve patient outcomes.
Latest Patents
Han Jie's latest patents include a groundbreaking invention titled "Protein and protein conjugate for diabetes treatment, and applications thereof." This invention relates to a protein and a protein conjugate that can be used in pharmaceutical compositions for treating diabetes. The fusion protein is created by linking two polypeptides, one being an interleukin-1 receptor antagonistic protein or an analogue, and the other being a GLP-1 receptor binding polypeptide or an analogue, among others. The fusion proteins and their conjugates demonstrate significant efficacy in treating diabetes, allowing for lower dosages and a marked reduction in side effects.
Career Highlights
Throughout his career, Han Jie has worked with various companies, including Adda Biotech Inc. His experience in the biopharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field.
Collaborations
Han Jie has collaborated with notable professionals, including his coworker Shulin Qin. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Han Jie is a distinguished inventor whose work in biopharmaceuticals is paving the way for new treatments for diabetes. His innovative approach and dedication to research continue to make a significant impact in the medical field.